Glad I taught you something about ORBIS. No idea if it is involved here.
As far as MHRA, the UK is obviously an ideal* commercial launch pad for artisan manufactured DCVax-l, and a perfect place to parallel test commercial EDEN units upon artisan commercialization.
* Geographical containment and highly advanced regulator for biotech industry, not to mention NWBO/Flaskworks/Advent presence/activity/manufacturing and facilities in UK.